Breaking News
Ad-Free Version. Upgrade your experience. Save up to 40% More details

'Gold rush': Race is on for health data in East Europe's frontier market

Stock MarketsJan 09, 2020 07:23
Saved. See Saved Items.
This article has already been saved in your Saved Items
© Reuters. People walk past insurance company Union HQ in Budapest

By Gergely Szakacs and Alicja Ptak

BUDAPEST/WARSAW (Reuters) - Eastern Europe is a new frontier for private medical care, and insurers and tech startups are racing to steal a march on their rivals by harnessing the region's health data.

Growing numbers of people in Eastern European states, from Hungary and Poland to Romania, are turning to private health. The shift is being driven by rising wages, coupled with low public health spending which has often led to staff shortages and long waiting times for tests and surgery.

Now big insurance players in the region, including PZU (WA:PZU), Generali (MI:GASI), Vienna Insurance Group (VIG) (VI:VIGR) and Allianz (DE:ALVG), are looking to gather and analyse patient data from the fast-growing market to improve risk assessments and pricing.

"Data is the foundation of the future," said Gabriella Almassy, general manager of VIG's Hungarian division, adding that data would be key to identifying where profits can me made in the region's increasingly competitive health insurance market.

To that end, many insurers are teaming up with technology companies such as Polish startup Infermedica, whose software analyses anonymised health information to provide preliminary diagnoses.

"We are seeing a health data boom that resembles the financial data boom from 10-15 years ago when the banking sector changed a lot," said Maciej Malenda, head of partnerships at Infermedica, which works with PZU and Allianz.

"Calling it a gold rush is perfectly accurate."

PZU, the region's biggest insurer, said it was also looking into dozens of other startups to help it expand its health business.

Health data is an increasingly coveted prize for insurers and technology companies globally.

The trend was illustrated by Google's (O:GOOGL) plans to buy fitness-tracker maker Fitbit (N:FIT) for $2.1 billion, announced late last year. The deal will bring the web giant a rich trove of data gathered by millions of Fitbit devices, which monitor users' daily steps, calories burned, heart rate and sleep quality, among other things.

Fitbit has already partnered with insurers, and analysts say much of its value may now lie in its health data.


The fledgling nature of the Eastern European private healthcare market presents rare opportunities, due to low market saturation compared with more mature Western markets, combined with rising consumer spending power - however it also poses the biggest obstacles for insurers.

Executives say a scarcity of data can make it difficult, or unwise, to identify trends and complicates the pricing of risk. They stress that it could take several years before investments in data collection and analysis pay off, although they declined to disclose spending figures, citing commercial sensitivity.

Attila Hevesi, a product development manager at Generali's Hungarian division, said there was no comparison between the quantity and quality of data available for health insurance and, for example, car insurance.

"The two are not on the same page," he said. "It is like a dolphin versus a blue whale. But maybe even a dolphin is an exaggeration."

In an illustration of the thinking of big insurers, Hevesi said Generali had struck a big health insurance deal with a large employer which could end up being loss-making, but it was willing to take the risk to build up its trove of patient data in the emerging Hungarian market.

He declined to give details about that deal, but said Generali was incrementally improving its pricing in Hungary as a result of data-gathering.

VIG's Czech division also said access to reliable health data was a problem.

"Today, we are pricing based on clients' data used for life insurance," said Kooperativa board member Filip Kral.


Another major challenge facing the nascent regional market is ensuring data privacy and security.

Companies handling personal data are required to protect confidentiality and need to put appropriate security measures in place to comply with stringent EU data protection rules.

However the risks of handling sensitive health information were illustrated in October when Hungary's National Institute of Pharmacy and Nutrition was hacked, with the data of thousands of patients leaked from pharmacies and drug wholesalers.

Elsewhere in Europe, a British hospital trust was rapped by privacy authorities two years ago for misusing data, after it passed on personal information of around 1.6 million patients to AI firm Google DeepMind.

Despite the potential pitfalls, however, many insurers looking to carve out a niche in Central and Eastern Europe's health market have little choice but to embrace data-gathering to improve pricing and profitability.

VIG, for example, is planning to steer many Hungarian customers to a self-service online platform this year, which would give the company more granular data on how patients use private health services.

In the first nine months of 2019, VIG's health insurance premium volumes rose to 513 million euros, with 62% of that coming from Austria and the rest from Central and Eastern Europe - but the group is banking on the latter to underpin its business in coming years, according to spokesman Wolfgang Haas.

"This is where we see the greatest potential for the future."

'Gold rush': Race is on for health data in East Europe's frontier market

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email